$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24 원문보기

Cancer research and treatment : official journal of Korean Cancer Association, v.50 no.1, 2018년, pp.40 - 49  

Park, Jinsung (Department of Urology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea) ,  Shin, Dong Wook (Department of Family Medicine, Seoul National University Hospital, Seoul, Korea) ,  Kim, Tae-Hwan (Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea) ,  Jung, Seung Il (Department of Urology, Chonnam National University Medical School, Gwangju, Korea) ,  Nam, Jong Kil (Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea) ,  Park, Seung Chol (Department of Urology, Wonkwang University School of Medicine, Iksan, Korea) ,  Hong, Sungwoo (Department of Urology, Dankook University College of Medicine, Cheonan, Korea) ,  Jung, Jae Hung (Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea) ,  Kim, Hongwook (Department of Urology, Konyang University College of Medicine, Daejeon, Korea) ,  Kim, Won Tae (Dep)

Abstract AI-Helper 아이콘AI-Helper

PurposeWe aimed to evaluate psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-NMIBC24 when applied to Korean non-muscle invasive bladder cancer (NMIBC) patients.Materials and MethodsA total of 249 patients who underwent curati...

Keyword

참고문헌 (17)

  1. 1 Joung JY Lim J Oh CM Jung KW Cho H Kim SH Current trends in the incidence and survival rate of urological cancers in Korea Cancer Res Treat 2017 49 607 15 27658388 

  2. 2 Jemal A Bray F Center MM Ferlay J Ward E Forman D Global cancer statistics CA Cancer J Clin 2011 61 69 90 21296855 

  3. 3 Nieder AM Mackinnon JA Huang Y Fleming LE Koniaris LG Lee DJ Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease J Urol 2008 179 491 5 18076917 

  4. 4 Kurth KH Denis L Bouffioux C Sylvester R Debruyne FM Pavone-Macaluso M Factors affecting recurrence and progression in superficial bladder tumours Eur J Cancer 1995 31A 1840 6 8541110 

  5. 5 Sylvester RJ van der Meijden AP Oosterlinck W Witjes JA Bouffioux C Denis L Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 2006 49 466 77 16442208 

  6. 6 Fernandez-Gomez J Madero R Solsona E Unda M Martinez-Pineiro L Gonzalez M Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model J Urol 2009 182 2195 203 19758621 

  7. 7 Barry MJ Helping patients make better personal health decisions: the promise of patient-centered outcomes research JAMA 2011 306 1258 9 21934062 

  8. 8 Blazeby JM Hall E Aaronson NK Lloyd L Waters R Kelly JD Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer Eur Urol 2014 66 1148 56 24612661 

  9. 9 EORTC Quality of Life Group EORTC Quality of Life Group Translation Procedure [Internet] Brussels EORTC Quality of Life Department 2014 [cited 2014 Mar 3]. Available from: http://groups.eortc.be/qol/manuals 

  10. 10 Yun YH Park YS Lee ES Bang SM Heo DS Park SY Validation of the Korean version of the EORTC QLQ-C30 Qual Life Res 2004 13 863 8 15129896 

  11. 11 Aaronson NK Ahmedzai S Bergman B Bullinger M Cull A Duez NJ The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 1993 85 365 76 8433390 

  12. 12 Shin DW Ahn E Kim YM Kang S Kim BG Seong SJ Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module Oncology 2009 76 190 8 19209009 

  13. 13 Dobbs RW Hugar LA Revenig LM Al-Qassab S Petros JA Ritenour CW Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer Int Braz J Urol 2014 40 198 203 24856486 

  14. 14 Richards KA Ham S Cohn JA Steinberg GD Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities Int J Urol 2016 23 42 7 26443388 

  15. 15 Benner C Greenberg M Shepard N Meng MV Rabow MW The natural history of symptoms and distress in patients and families following cystectomy for treatment of muscle invasive bladder cancer J Urol 2014 191 937 42 24184369 

  16. 16 Palapattu GS Haisfield-Wolfe ME Walker JM BrintzenhofeSzoc K Trock B Zabora J Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer J Urol 2004 172 5 Pt 1 1814 7 15540727 

  17. 17 Kowalkowski MA Chandrashekar A Amiel GE Lerner SP Wittmann DA Latini DM Examining sexual dysfunction in non-muscle-invasive bladder cancer: results of cross-sectional mixed-methods research Sex Med 2014 2 141 51 25356311 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로